Literature DB >> 6849772

No significant effect of metoclopramide on misonidazole elimination in man.

K M Williams, E J Begg, D N Wade, K O'Shea.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6849772      PMCID： PMC1427787          DOI： 10.1111/j.1365-2125.1983.tb01519.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum.

Authors:  M E Saunders; S Dische; P Anderson; I R Flockhart
Journal:  Br J Cancer Suppl       Date:  1978-06

2.  Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.

Authors:  P Workman; N M Bleehen; C R Wiltshire
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

3.  Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.

Authors:  S Dische; M I Saunders; M E Lee; G E Adams; I R Flockhart
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

4.  Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.

Authors:  P Workman
Journal:  Br J Cancer       Date:  1979-09       Impact factor: 7.640
  4 in total
  2 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.